MIR1197: A Potential Drug Target and Biomarker (G100302250)
MIR1197: A Potential Drug Target and Biomarker
MIR1197, a protein that is expressed in various tissues of the body, has been identified as a potential drug target and biomarker. Its unique structure and function have made it an attractive target for drug development, especially for diseases that involve inflammation and cellular signaling.
MIR1197 is a member of the superfamily of cytoplasmic efflux proteins (SCAPs), which are known for their ability to transport proteins out of cells and contribute to the regulation of cellular signaling pathways. SCAPs are involved in a wide range of cellular processes, including cell signaling, cytoskeletal organization, and cell survival.
MIR1197 is a 19-kDa protein that is expressed in various tissues of the body, including the brain, heart, liver, and kidneys. It is localized to the endoplasmic reticulum (ER) and is involved in the regulation of several cellular signaling pathways.
One of the most significant functions of MIR1197 is its role in the regulation of the TGF-β pathway, which is a well-known signaling pathway that is involved in cell growth, differentiation, and survival. TGF-β signaling is a critical pathway that regulates the development and maintenance of tissues, and MIR1197 has been shown to play a key role in its regulation.
MIR1197 is known to interact with the transcription factor, p53, and the protein, p21. These interactions are important for the regulation of cellular processes, including cell growth, apoptosis, and survival. MIR1197 has also been shown to play a role in the regulation of the NF-kappa-B pathway, a signaling pathway that is involved in inflammation and cellular signaling.
MIR1197 has also been shown to be involved in the regulation of several other signaling pathways, including the PI3K/Akt signaling pathway, the T-cell receptor (TCR) signaling pathway, and the NF-E2 signaling pathway. These signaling pathways are important for the regulation of cellular processes, including cell growth, differentiation, and survival.
MIR1197 has also been shown to be involved in the regulation of cellular transport processes. It is a member of the SCAP family of proteins, which are known for their ability to transport proteins out of cells. This function is important for the regulation of cellular processes, including the regulation of ion and solute transport.
In addition to its role in cellular signaling pathways, MIR1197 has also been shown to be involved in the regulation of several cellular processes, including cell adhesion, migration, and the regulation of cell death. These functions are important for the regulation of cellular processes, including tissue formation and maintenance, and are critical for the development and maintenance of tissues.
MIR1197 has also been shown to be involved in the regulation of cellular interactions with the extracellular matrix (ECM). The ECM is a matrix of proteins that is present in the cytoplasm of cells, and it plays a critical role in the regulation of cellular processes, including cell adhesion and migration. MIR1197 has been shown to play a role in the regulation of these processes, which are important for the development and maintenance of tissues.
MIR1197 has also been shown to be involved in the regulation of cellular interactions with other cells and tissues. This function is important for the regulation of cellular processes, including inflammation and immune responses. MIR1197 has been shown to play a role in the regulation of these processes, which are critical for the survival and health of multicellular organisms.
In conclusion, MIR1197 is a protein that is involved in several cellular signaling pathways and has been shown to play a role in the regulation of several cellular processes, including TGF-β, NF-kappa-B, PI3K/Akt, TCR, and NF-E2 signaling pathways. Its unique structure and function make it an attractive target for drug development, especially for diseases that involve inflammation and cellular signaling. Further research is needed to fully understand the role of MIR1197 in cellular processes and its potential as a drug target.
Protein Name: MicroRNA 1197
The "MIR1197 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1197 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR1199 | MIR1200 | MIR1202 | MIR1203 | MIR1204 | MIR1205 | MIR1206 | MIR1207 | MIR1208 | MIR12129 | MIR12135 | MIR12136 | MIR122 | MIR1224 | MIR1225 | MIR1226 | MIR1227 | MIR1228 | MIR1229 | MIR1231 | MIR1233-1 | MIR1233-2 | MIR1234 | MIR1236 | MIR1237 | MIR1238 | MIR124-1 | MIR124-1HG | MIR124-2 | MIR124-2HG | MIR124-3 | MIR1243 | MIR1244-1 | MIR1244-2 | MIR1244-3 | MIR1245A | MIR1245B | MIR1246 | MIR1247 | MIR1248 | MIR1249 | MIR1250 | MIR1251 | MIR1252 | MIR1253 | MIR1254 | MIR1255A | MIR1255B1 | MIR1255B2 | MIR1256 | MIR1257 | MIR1258 | MIR125A | MIR125B1 | MIR125B2 | MIR126 | MIR1260A | MIR1260B | MIR1261 | MIR1262 | MIR1263 | MIR1264 | MIR1265 | MIR1266 | MIR1267 | MIR1268A | MIR1268B | MIR1269A | MIR1269B | MIR127 | MIR1270 | MIR1271 | MIR1272 | MIR1273A | MIR1273C | MIR1273H | MIR1275 | MIR1276 | MIR1277 | MIR1278 | MIR1279 | MIR128-1 | MIR128-2 | MIR1280 | MIR1281 | MIR1282 | MIR1283-1 | MIR1283-2 | MIR1284 | MIR1285-1 | MIR1285-2 | MIR1286 | MIR1287 | MIR1288 | MIR1289-1 | MIR1289-2 | MIR129-1 | MIR129-2 | MIR1290 | MIR1291
